1-15465931-C-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_033440.3(CELA2A):​c.494-68C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.216 in 1,569,754 control chromosomes in the GnomAD database, including 45,287 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.32 ( 11165 hom., cov: 31)
Exomes 𝑓: 0.20 ( 34122 hom. )

Consequence

CELA2A
NM_033440.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.74

Publications

18 publications found
Variant links:
Genes affected
CELA2A (HGNC:24609): (chymotrypsin like elastase 2A) Elastases form a subfamily of serine proteases that hydrolyze many proteins in addition to elastin. Humans have six elastase genes which encode the structurally similar proteins elastase 1, 2, 2A, 2B, 3A, and 3B. Like most of the human elastases, elastase 2A is secreted from the pancreas as a zymogen. In other species, elastase 2A has been shown to preferentially cleave proteins after leucine, methionine, and phenylalanine residues. [provided by RefSeq, May 2009]
CELA2B (HGNC:29995): (chymotrypsin like elastase 2B) Elastases form a subfamily of serine proteases that hydrolyze many proteins in addition to elastin. Humans have six elastase genes which encode the structurally similar proteins elastase 1, 2, 2A, 2B, 3A, and 3B. Like most of the human elastases, elastase 2B is secreted from the pancreas as a zymogen. In other species, elastase 2B has been shown to preferentially cleave proteins after leucine, methionine, and phenylalanine residues. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.641 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CELA2ANM_033440.3 linkc.494-68C>G intron_variant Intron 5 of 7 ENST00000359621.5 NP_254275.1 P08217
LOC105376767XR_002958256.2 linkn.367-1059G>C intron_variant Intron 1 of 2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CELA2AENST00000359621.5 linkc.494-68C>G intron_variant Intron 5 of 7 1 NM_033440.3 ENSP00000352639.4 P08217
CELA2BENST00000494280.1 linkn.23C>G non_coding_transcript_exon_variant Exon 1 of 6 5

Frequencies

GnomAD3 genomes
AF:
0.322
AC:
48950
AN:
151904
Hom.:
11136
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.647
Gnomad AMI
AF:
0.178
Gnomad AMR
AF:
0.210
Gnomad ASJ
AF:
0.233
Gnomad EAS
AF:
0.0765
Gnomad SAS
AF:
0.184
Gnomad FIN
AF:
0.211
Gnomad MID
AF:
0.269
Gnomad NFE
AF:
0.203
Gnomad OTH
AF:
0.312
GnomAD4 exome
AF:
0.205
AC:
290259
AN:
1417732
Hom.:
34122
Cov.:
25
AF XY:
0.204
AC XY:
144363
AN XY:
706034
show subpopulations
African (AFR)
AF:
0.652
AC:
21197
AN:
32492
American (AMR)
AF:
0.140
AC:
6176
AN:
44204
Ashkenazi Jewish (ASJ)
AF:
0.245
AC:
6185
AN:
25246
East Asian (EAS)
AF:
0.0872
AC:
3435
AN:
39372
South Asian (SAS)
AF:
0.208
AC:
17585
AN:
84512
European-Finnish (FIN)
AF:
0.207
AC:
10841
AN:
52402
Middle Eastern (MID)
AF:
0.268
AC:
1206
AN:
4498
European-Non Finnish (NFE)
AF:
0.196
AC:
210456
AN:
1076182
Other (OTH)
AF:
0.224
AC:
13178
AN:
58824
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
11007
22014
33021
44028
55035
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
7270
14540
21810
29080
36350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.322
AC:
49027
AN:
152022
Hom.:
11165
Cov.:
31
AF XY:
0.317
AC XY:
23527
AN XY:
74306
show subpopulations
African (AFR)
AF:
0.647
AC:
26830
AN:
41444
American (AMR)
AF:
0.210
AC:
3207
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
0.233
AC:
808
AN:
3470
East Asian (EAS)
AF:
0.0768
AC:
398
AN:
5180
South Asian (SAS)
AF:
0.183
AC:
881
AN:
4820
European-Finnish (FIN)
AF:
0.211
AC:
2228
AN:
10548
Middle Eastern (MID)
AF:
0.286
AC:
84
AN:
294
European-Non Finnish (NFE)
AF:
0.203
AC:
13776
AN:
67982
Other (OTH)
AF:
0.310
AC:
653
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1382
2764
4147
5529
6911
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
432
864
1296
1728
2160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.193
Hom.:
1777
Bravo
AF:
0.339
Asia WGS
AF:
0.186
AC:
644
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
0.83
DANN
Benign
0.39
PhyloP100
-1.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2901964; hg19: chr1-15792426; COSMIC: COSV62747293; COSMIC: COSV62747293; API